The human body is still a mystery, and some organs have largely been considered useless in one way or another. However, the ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get the AARP Now app. New and improved, it’s the app that makes ...

US FDA grants Breakthrough Therapy designation to Sanofi’s venglustat for type 3 Gaucher disease: Paris Thursday, March 19, 2026, 10:00 Hrs [IST] Sanofi announced that the US Fo ...

Gaucher disease is a rare inherited disorder in which fatty substances accumulate inside certain cells, gradually damaging organs such as the spleen, liver and bones. The condition occurs due to a ...

Sanofi has received Breakthrough Therapy designation from the US FDA for venglustat, an investigational oral drug targeting neurological symptoms of type 3 Gaucher disease, a rare genetic disorder ...

Studies are showing that the inflammatory condition can impact organs across the body, not just those involved in ...

Gaucher is a rare genetic condition that causes fatty substance build up in the tissues of spleen, liver and bones and ultimately causes damage and dy.

As a meningitis outbreak in the UK raises concern, authorities urge vaccinations and antibiotics. Experts highlight a key warning sign: a rash that does not fade under pressure, which may indicate ...

Sanofi's venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Paris, March 18, 2026. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy design ...

The U.S. Food and Drug Administration has granted breakthrough therapy designation to Sanofi’s (SNY) venglustat, a novel, investigational oral glucosylceramide synthase inhibitor (GCSi), for the ...

The lymphatic system is part of the human immune system. It’s a collection of tissues and vessels that move a fluid called lymph throughout the body. A lymphatic drainage massag ...